Merck Sharp & Dohme Corp. et al. v. Dr. Reddy’s Laboratories Ltd.
T-249-21; T-250-21; T-251-21; T-252-21
Actions under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,450,740, No. 2,529,400 and No. 2,536,251 as well as patent infringement actions relating to Patent No. 2,518,435 with respect to products containing sitagliptin and products containing both sitagliptin and metformin.
Dr. Reddy’s Laboratories Ltd.
The decision is reported